Statements of each of our partnership institutions in light of the murder of George Floyd

FDA Approval

We are excited to announce that Tissue Modeling Core Co-Leader Dr Paul Okunieff and the company he founded DiaCarta have received FDA approval for their Covid-19 Test that is able to detect covid-19 variants using an algorithm they developed.

https://www.prnewswire.com/news-releases/diacartas-multivariant-covid-19-test-accurately-detects-the-omicron-variant-301434105.html?tc=eml_cleartime
Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest

Subscribe to Our Newsletter

Stay up to date with the latest news and information about Care2

Facebook-f Twitter Instagram Linkedin

All Rights Reserved © 2020